FIELD: pharmacology.
SUBSTANCE: group of inventions discloses a system for sterile obtaining of lipids and nucleic acids nanoparticles and method for sterile obtaining of lipids and nucleic acids nanoparticles.
EFFECT: group of inventions allows to obtain uniform lipid and nucleic acid particles by simple steps, reproducible and under aseptic conditions, and can be used to deliver this class of therapeutic molecules to target cells.
23 cl, 13 tbl, 7 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING LIPID NANOPARTICLES FOR DRUG DELIVERY | 2012 |
|
RU2647476C2 |
| LIPID PARTICLES CONTAINING NUCLEIC ACIDS AND RELATED METHODS | 2010 |
|
RU2573409C2 |
| TRIALKYL CATIONIC LIPIDS AND METHODS FOR USING THEM | 2013 |
|
RU2718053C2 |
| STABLE COMPOSITIONS OF LIPIDS AND LIPOSOMES | 2015 |
|
RU2738060C2 |
| NOVEL LOW-MOLECULAR CATIONIC LIPIDS FOR DELIVERY OF OLIGONUCLEOTIDES | 2011 |
|
RU2617641C2 |
| METHOD OF T-CELL ACTIVATION/PROLIFERATION | 2019 |
|
RU2806549C2 |
| LIPID NANOPARTICLES FOR IN VIVO MEDICINAL PRODUCTS DELIVERY AND THEIR USE | 2020 |
|
RU2799045C1 |
| NUCLEIC ACID COMPLEXES AS LIGANDS OF VESICAL ENDOTHELIAL GROWTH FACTOR (VEGF) | 1997 |
|
RU2177950C2 |
| COMPOSITION FOR INHIBITING GROWTH AND STIMULATION OF APOPTOSIS OF COLORECTAL CANCER CELLS | 2016 |
|
RU2644675C1 |
| CATIONIC LIPIDS | 2018 |
|
RU2782218C2 |
